重度OSAHS患者治療前后MMP-9和FFA水平變化及意義
本文選題:睡眠呼吸暫停低通氣綜合征 + 基質(zhì)金屬蛋白酶P-9; 參考:《南華大學(xué)》2010年碩士論文
【摘要】: 目的 對(duì)成人重度阻塞性睡眠呼吸暫停低通氣綜合征(OSAHS)患者治療前后基質(zhì)金屬蛋白酶p-9(MMP-9)和游離脂肪酸(FFA)水平變化進(jìn)行跟蹤隨訪監(jiān)測(cè),從而探討MMP-9及FFA與OSAHS患者呼吸紊亂指數(shù)、最低血氧飽和度及血脂相關(guān)性,為OSAHS病情程度及療效評(píng)估提供相關(guān)的依據(jù)。 方法 對(duì)38例擁有完整病例并符合納入條件的經(jīng)PSG監(jiān)測(cè)診斷為重度OSAHS患者,抽取清晨空腹血測(cè)試MMP-9、FFA、及臨床常規(guī)血脂四項(xiàng)(TG、TC、HDL、LDL)。對(duì)患者進(jìn)行手術(shù)(H-UPPP術(shù))解除氣道阻塞,并于術(shù)前一周給予CPAP治療。對(duì)其治療前和治療后3個(gè)月相應(yīng)指標(biāo)做出比較。將所得數(shù)據(jù)進(jìn)行SPSS16.0統(tǒng)計(jì)學(xué)軟件處理分析并得出結(jié)論。 結(jié)果 1.OSAHS患者經(jīng)治療后:LSaO2明顯上升(P0.01),AHI明顯下降(P0.01),有統(tǒng)計(jì)學(xué)意義。 2.OSAHS患者經(jīng)治療后:血清MMP-9值、FFA值顯著下降(P0.01),有統(tǒng)計(jì)學(xué)意義。 3.OSAHS患者經(jīng)治療后:血脂四項(xiàng)中TG、TC、LDL值下降(P0.01),HDL值上升(P0.01),有統(tǒng)計(jì)學(xué)意義。 4 .MMP-9、FFA與AHI、LSaO2、TG、TC、HDL及LDL ,經(jīng)逐步回歸分析:AHI、LSaO2、TG與MMP-9、FFA關(guān)系最密切,對(duì)OSAHS患者體內(nèi)MMP-9、FFA影響最明顯( P0.01),有統(tǒng)計(jì)學(xué)意義。 5. MMP-9、FFA與AHI、LSaO2、TG、TC、HDL及LDL,經(jīng)相關(guān)分析:FFA與AHI、TG成正相關(guān)( P0.01),與LSaO2、HDL成負(fù)相關(guān)( P0.05),有統(tǒng)計(jì)學(xué)意義;MMP-9與AHI、TG成正相關(guān)( P0.01),與LSaO2成負(fù)相關(guān)( P0.01),有統(tǒng)計(jì)學(xué)意義。MMP-9和FFA與TC、LDL成正相關(guān)( P0.05),無統(tǒng)計(jì)學(xué)意義。 6.MMP-9與FFA經(jīng)直線回歸分析:MMP-9與FFA成正相關(guān)( P0.01),有統(tǒng)計(jì)學(xué)意義。 結(jié)論 1.有效的治療OSAHS,可以降低MMP-9與FFA的水平。 2. MMP-9和FFA可以作為評(píng)估OSAHS患者病情嚴(yán)重程度的重要指標(biāo)之一。
[Abstract]:Purpose The changes of matrix metalloproteinase p-9 (MMP-9) and free fatty acid (FFA) levels in adult patients with severe obstructive sleep apnea hypopnea syndrome (OSAHS) before and after treatment were followed up, and the respiratory disturbance index of patients with MMP-9, FFA and OSAHS were investigated. The correlation between minimum oxygen saturation and blood lipids may provide relevant evidence for the evaluation of the severity and curative effect of OSAHS. Method A total of 38 patients with severe OSAHS diagnosed by PSG monitoring were selected for early morning fasting blood samples for testing MMP-9 FFAs, and four items of routine blood lipids, TGG TCC and HDLL, were collected from 38 patients who were diagnosed as severe OSAHS by PSG monitoring. The airway obstruction was relieved by H-UPPP and CPAP was given one week before operation. The corresponding indexes before treatment and 3 months after treatment were compared. The data are processed and analyzed by SPSS16.0 statistical software and the conclusion is drawn. Result After the treatment of 1.OSAHS patients, the ratio of w / L SaO2 increased significantly (P 0.01) and decreased significantly (P 0.01). After treatment, the serum MMP-9 value and FFA value of 2.OSAHS patients decreased significantly (P 0.01). After treatment, there was a significant difference between the four items of serum lipids, the decrease of TGG TCU LDL value and the increase of HDL value (P 0.01 and P 0.01) in the patients with 3.OSAHS. 4. MMP-9 FFA was most closely related to TGG and LDL by stepwise regression analysis, and had the most significant effect on MMP-9 FFA in patients with OSAHS (P0.01, P 0.01, P < 0.05). 5. MMP-9 FFA was positively correlated with AHI LSAO 2 TGG TCU HDL and LDL. The positive correlation was found between FFA and TG (P0.01), and negative correlation was found with LSaO2 HDL (P0.05). There was a significant positive correlation between MMP-9 and LSaO2 (P0.01, MMP-9, FFA and TCLDL) (P0.05P, no statistical significance). 6.MMP-9 and FFA were positively correlated with FFA by linear regression analysis (P 0.01). Conclusion 1. Effective treatment of OSAHS can reduce the levels of MMP-9 and FFA. 2. MMP-9 and FFA can be used as an important index to evaluate the severity of OSAHS.
【學(xué)位授予單位】:南華大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2010
【分類號(hào)】:R766
【參考文獻(xiàn)】
相關(guān)期刊論文 前7條
1 李宏亮,余葉蓉,喻紅玲,王椿,張祥迅;單純性肥胖患者外周胰島素抵抗與兀細(xì)胞功能的研究[J];四川大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2005年03期
2 余葉蓉;李宏亮;張祥迅;;高游離脂肪酸血癥對(duì)SD大鼠主動(dòng)脈內(nèi)皮細(xì)胞一氧化氮合酶活性及mRNA表達(dá)的影響[J];四川大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2008年02期
3 張俊峰;葛恒;郭炳詩;邵琴;王長謙;;細(xì)胞外基質(zhì)金屬蛋白酶誘導(dǎo)因子在巨噬和泡沫細(xì)胞中的表達(dá)[J];上海交通大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2006年03期
4 彭寧;劉俊田;;血管緊張素Ⅱ誘導(dǎo)活性氧簇的產(chǎn)生及其在血管損傷的信號(hào)機(jī)制[J];生理科學(xué)進(jìn)展;2006年04期
5 姜昕,曾和松,郭毅,周志斌,唐冰杉,李富康;The expression of matrix metalloproteinases-9, transforming growth factor-β1 and transforming growth factor-β receptorⅠ in human atherosclerotic plaque and their relationship with plaque stability[J];Chinese Medical Journal;2004年12期
6 ;Increased serum levels of C-reactive protein and matrix metalloproteinase-9 in obstructive sleep apnea syndrome[J];Chinese Medical Journal;2007年17期
7 牛占叢,平芬,李賢,趙景春;OSAHS、OSAHAHT患者血清基質(zhì)金屬蛋白酶9及其抑制因子水平[J];中國老年學(xué)雜志;2005年08期
,本文編號(hào):1928846
本文鏈接:http://sikaile.net/yixuelunwen/yank/1928846.html